Having made significant contributions to surgery for more than a century, the Johnson & Johnson Medical Devices Companies are in the business of reaching more patients and restoring more lives. The group represents the most comprehensive surgical technology and specialty solutions business in the world, offering an unparalleled breadth of products, services, programs and research and development capabilities directed at advancing patient care while delivering clinical and economic value to health care systems worldwide.
Medtronic plc, headquartered in Dublin, Ireland, is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 88,000 people worldwide, serving physicians, hospitals and patients in approximately 160 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.
Seroba Life Sciences is a life sciences venture capital firm, focused on investing in breakthrough healthcare technologies that promise to improve lives and make a difference worldwide.
Headquartered in Ireland, we work with some of Europe and the world’s best entrepreneurs developing innovative medical devices, diagnostics and therapeutic drugs. We fund new healthcare opportunities through key value-adding stages, from inception through development and clinical evaluation, the generation of intellectual property, regulatory approvals and market launch and partnering with leading pharmaceutical or medtech companies.
Our team combines in-depth scientific and medical knowledge with broad regulatory and commercial expertise. We are known for patience, understanding, commitment and passion, well-demonstrated by the calibre of entrepreneurs we back, and an overriding focus on delivering improvements to people’s lives and value to our stakeholders.
Created in 1979 by the healthcare technology industry, Medmarc’s purpose is to be the superior provider of liability insurance and related risk management solutions and to support the development, testing and delivery of medical products that save lives and improve the quality of life. Through collaboration with our parent company, ProAssurance, and our clinical trial industry experts, we provide a single source of innovative healthcare liability insurance solutions to the life sciences companies we serve. From ideas and prototypes to the reality of commercialization and success – We can Meet Your Changing Needs.
Call me to discuss the cost of insurance coverage, what coverages are needed and when for your business plan: George Ayd (703) 652-1309.
Eugene F Collins provides a comprehensive legal service which is focused on delivering to clients commercial and pragmatic solutions to enable them to run their business more effectively and successfully. We have an expert team of people who have gained wide experience in diverse areas of law. This allows us to offer clients a specifically tailored service to deliver the commercially-focused solutions they require from a legal partner.
EY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.
CBSET Inc. is a nonprofit biomedical research institute with a mission is to advance therapeutics development through high-quality services. We collaborate with med tech and pharmaceutical sponsors with a GLP-compliant, AAALAC-accredited facility including vivaria, catheterization/imaging labs, surgical and necropsy suites, histopathology, SEM, and a range of other technologies.
As a specialized medical device CRO, genae is involved in the development and commercialization of investigational products and therapies that change medical practice. Our expertise helps you in obtaining predictable outcomes, on time, and on budget.
ICON plc is a global provider of clinical development solutions and services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support clinical development. With headquarters in Dublin, Ireland, ICON currently, operates from 84 locations in 38 countries and has approximately 12,300 employees.
IMMR (previously IMM Recherche) is a Contract Research Organization specialized in preclinical surgical research. With years of experience and a cutting-edge surgical and housing facility, we are the laboratory of choice for your in vivo medical device testing.
Our main focus is on early research and development studies, Good Laboratory Practice (GLP 21 CRF part 58) compliant studies (successfully inspected by the FDA), surgical training, histopathology of explanted soft and hard tissue.
We can service your projects from the early phases of technical feasibility all the way to the final report with histopathology, requested for your regulatory submission to notified bodies.
Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing in breakthrough life science companies during a time of unique opportunity in the space.
Members of the Lightstone team have worked together on numerous new life science enterprises over the last decade. We have similar styles and strategies and have demonstrated success and staying power with our legacy portfolio companies through market ups and downs. Members of the Lightstone team manage a portfolio of more than 50 medical device and biotechnology companies across the ATV and Morgenthaler legacy funds (Legacy Funds).
Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare.